Skip to main content
LNG Energy Group logo

LNG Energy Group — Investor Relations & Filings

Ticker · LNGE ISIN · CA53951J1066 LEI · 9845006FE499E88AC918 TSXV Mining and quarrying
Filings indexed 298 across all filing types
Latest filing 2021-02-03 Capital/Financing Update
Country CA Canada
Listing TSXV LNGE

About LNG Energy Group

https://www.lngenergygroup.com/

LNG Energy Group is an Exploration and Production (E&P) company focused on the acquisition and development of natural gas production and exploration assets. The company's strategic objective is to build a premier energy platform within Latin America, leveraging extensive natural reserves and industry experience. It operates as a key player in the region's energy sector, dedicated to delivering natural gas supplies.

Recent filings

Filing Released Lang Actions
Decision Document (Final).pdf
Capital/Financing Update Classification · 95% confidence The document is a receipt issued by the British Columbia Securities Commission and other Canadian provincial securities regulators for a Short Form Prospectus dated February 3, 2021. It is a regulatory acknowledgment of the filing of a prospectus, which is related to capital raising activities. The document is short (1118 characters) and serves as an official receipt rather than the prospectus itself or a detailed financial report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-02-03 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing an upcoming investor webinar hosted by senior management to provide a corporate update on recent developments. It includes details about the webinar date, time, registration link, and contact information. There is no substantive financial data, detailed financial results, or comprehensive report content. The document is short (3489 characters) and serves as an announcement rather than a full report or transcript. It does not contain a transcript of the webinar or detailed investor presentation slides, only an announcement of the event. Therefore, it fits best as an Investor Presentation (IP) announcement or a Regulatory Filing (RNS). However, since it is primarily an announcement of a webinar event and not the presentation itself, and given the lack of detailed financial or strategic content, the most appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2021-02-03 English
Final short form prospectus – English.pdf
Capital/Financing Update Classification · 95% confidence The document is a short form prospectus for a new issue of securities by Mind Cure Health Inc., dated February 3, 2021. It details the offering of units, underwriting agreement, pricing, and distribution plan. The text includes legal disclaimers about securities registration and offering jurisdictions, typical of a prospectus used in capital raising. There is no financial performance data, earnings information, or management discussion of results. The document is clearly related to a capital raising event and financing terms. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual prospectus, not just an announcement of a report. Hence, the classification is CAP with high confidence.
2021-02-03 English
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from DLA Piper (Canada) LLP providing consent for the use of their name and opinions in a Short Form Prospectus dated February 3, 2021. It references the Final Prospectus related to the sale of units of the company. The document is short (1740 characters) and does not contain financial data or the prospectus itself, but rather a legal consent related to the prospectus. This type of document is a regulatory filing related to the prospectus but is not the prospectus itself or a financial report. Therefore, it fits best under Regulatory Filings (RNS).
2021-02-03 English
Consent letter of issuer's legal counsel.pdf
Capital/Financing Update Classification · 95% confidence The document is a consent letter from a law firm (Farris LLP) regarding a Final Short Form Prospectus for Mind Cure Health Inc. dated February 3, 2021. It references the prospectus qualifying the distribution of units and confirms no misrepresentations in the legal opinions used in the prospectus. The document is short (1683 characters) and is clearly related to a capital raising activity (distribution of units). It is not the prospectus itself but a supporting legal consent document. This type of document is best classified under Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes.
2021-02-03 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Mind Cure Health Inc. It details a material change event involving a bought deal public offering of units, including the terms of the offering, underwriters, pricing, and proceeds. The document includes news releases announcing the offering and its upsizing. The content focuses on a financing transaction and capital raising activity, with detailed descriptions of the offering structure, underwriter fees, and use of proceeds. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive details about the financing, not merely an announcement or a brief summary. Therefore, the appropriate classification is CAP with high confidence.
2021-02-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.